Ustekinumab, sold under the brand name Stelara among others, is a monoclonal antibody medication used for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, [31] targeting both IL-12 and IL-23. [32]

Learn about STELARA® (ustekinumab), a biologic used for Crohn’s disease, ulcerative colitis, plaque psoriasis & psoriatic arthritis treatment. See Full Prescribing & Safety Info.

Dec 20, 2024 · Ustekinumab is a biologic drug that was originally approved to treat moderate to severe plaque psoriasis. Ustekinumab is now also approved to be used for psoriatic arthritis, Crohn’s disease and ulcerative colitis.

Jul 19, 2021 · Ustekinumab is a human monoclonal antibody typically used to treat moderate to severe plaque psoriasis, psoriatic arthritis, moderate to severe Crohn disease, or moderate to severe ulcerative colitis (inflammatory bowel disease).

Dec 20, 2024 · Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Stelara is an interleukin inhibitor that blocks IL-12 and IL-23.

Stelara (ustekinumab) is commonly used to treat the following inflammatory conditions. Moderate to severe plaque psoriasis, which is a skin condition; Psoriatic arthritis, which is a type of...

Ustekinumab injection products are used to treat moderate to severe plaque psoriasis (skin disease in which red, scaly patches form on some areas of the body) in adults and children 6 years or older who may benefit from medications or phototherapy (a treatment that involves exposing the skin to ultraviolet light).

Stelara® is a brand of ustekinumab that treats plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. This medication treats symptoms of these conditions and it isn’t a cure. A healthcare provider usually gives you this injection in a hospital or clinic setting.

Nov 18, 2007 · Ustekinumab is a targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis.

Description for Steqeyma. Ustekinumab-stba, a human IgG1κ monoclonal antibody, is a human interleukin-12 and -23 antagonist.Using DNA recombinant technology, ustekinumab-stba is produced in a Chinese Hamster Ovary (CHO) cell line. The manufacturing process contains steps for the clearance of viruses.Ustekinumab-stba is comprised of 1326 amino acids and has an …